The combination of soluble tumor necrosis factor receptor type 1 and fibroblast growth factor 21 exhibits better prediction of renal outcomes in patients with type 2 diabetes mellitus.

Details

Language :

English

ISSN :

03914097

Volume :

44

Issue :

12

Database :

Complementary Index

Journal :

Journal of Endocrinological Investigation

Publication Type :

Academic Journal

Accession number :

153436039

Full Text :

https://doi.org/10.1007/s40618-021-01568-7